Inventor
EMERSON RYAN O
US13 patents
⚠️ This page may combine multiple inventors who share the name “EMERSON RYAN O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADAPTIVE BIOTECHNOLOGIES CORP
12 patentsUS9371558B2Jun 21, 2016
Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
ADAPTIVE BIOTECHNOLOGIES CORP23 citations90
US10392663B2Aug 27, 2019
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples
ADAPTIVE BIOTECHNOLOGIES CORP12 citations83
US10214770B2Feb 26, 2019
Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
ADAPTIVE BIOTECHNOLOGIES CORP7 citations82
US10150996B2Dec 11, 2018
Quantification of adaptive immune cell genomes in a complex mixture of cells
ADAPTIVE BIOTECHNOLOGIES CORP12 citations82
US11254980B1Feb 22, 2022
Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
ADAPTIVE BIOTECHNOLOGIES CORP2 citations72
US10246701B2Apr 2, 2019
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
ADAPTIVE BIOTECHNOLOGIES CORP7 citations68
US10894977B2Jan 19, 2021
Compositions and methods for measuring and calibrating amplification bias in multiplexed PCR reactions
ADAPTIVE BIOTECHNOLOGIES CORP0 citations60
US12104211B2Oct 1, 2024
Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
ADAPTIVE BIOTECHNOLOGIES CORP0 citations59
US11066705B2Jul 20, 2021
Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
ADAPTIVE BIOTECHNOLOGIES CORP0 citations55
US12428682B2Sep 30, 2025
Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
ADAPTIVE BIOTECHNOLOGIES CORP0 citations54
US11047008B2Jun 29, 2021
Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
ADAPTIVE BIOTECHNOLOGIES CORP0 citations54
US11248253B2Feb 15, 2022
Methods using randomer-containing synthetic molecules
ADAPTIVE BIOTECHNOLOGIES CORP0 citations47